A randomised Phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium
Latest Information Update: 07 Oct 2021
At a glance
- Drugs Cabazitaxel (Primary) ; Vinflunine
- Indications Bladder cancer; Renal cancer; Urethral cancer
- Focus Therapeutic Use
- 05 Oct 2021 This trial has been completed in Spain, according to European Clinical Trials Database
- 13 Apr 2017 Results of phase II part of the study (n=70) published in the Annals of Oncology
- 18 Feb 2017 Primary endpoint of overall response rate has not been met, according to results presented at the 2017 Genitourinary Cancers Symposium..